Publications:

Complete and Durable Response to Nivolumab in Recurrent Poorly Differentiated Pancreatic Neuroendocrine Carcinoma with High Tumor Mutational Burden.

Current Oncology (Toronto, Ont.)

Kang, Nai-Wen NW; Tan, Kien-Thiam KT; Li, Chien-Feng CF; Kuo, Yu-Hsuan YH

Publication Date: 2021-11-10

Variant appearance in text: TERT: 2476G>A; Val826Ile

PubMed Link: 34898561

Variant Present in the following documents:

• Main text
• curroncol-28-00388.pdf

View BVdb publication page

Complete and Durable Response to Nivolumab in Recurrent Poorly Differentiated Pancreatic Neuroendocrine Carcinoma with High Tumor Mutational Burden.

Current Oncology (Toronto, Ont.)

Kang, Nai-Wen NW; Tan, Kien-Thiam KT; Li, Chien-Feng CF; Kuo, Yu-Hsuan YH

Publication Date: 2021-11-10

Variant appearance in text: TERT: 2476G>A; Val826Ile

PubMed Link: 34898561

Variant Present in the following documents:

• Main text
• curroncol-28-00388.pdf

View BVdb publication page

Phase and context shape the function of composite oncogenic mutations.

Nature

Gorelick, Alexander N AN; Sánchez-Rivera, Francisco J FJ; Cai, Yanyan Y; Bielski, Craig M CM; Biederstedt, Evan E; Jonsson, Philip P; Richards, Allison L AL; Vasan, Neil N; Penson, Alexander V AV; Friedman, Noah D ND; Ho, Yu-Jui YJ; Baslan, Timour T; Bandlamudi, Chaitanya C; Scaltriti, Maurizio M; Schultz, Nikolaus N; Lowe, Scott W SW; Reznik, Ed E; Taylor, Barry S BS

Publication Date: 2020-06

Variant appearance in text: TERT: V826I

PubMed Link: 32461694

Variant Present in the following documents:

• NIHMS1582596-supplement-1582596_Supp_Tab1-5.xlsx, sheet 2

View BVdb publication page